OptimizeRx Corporation reiterated financial guidance for the full year 2024. For the year, the company expects revenue to be at least $100 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | -1.19% | +10.01% | -30.12% |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.12% | 182M | |
+18.80% | 413B | |
+14.91% | 241B | |
+9.47% | 140B | |
+19.18% | 103B | |
+17.60% | 83.94B | |
+52.33% | 56.98B | |
+33.60% | 53.38B | |
+5.85% | 37.77B | |
+15.64% | 34.36B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024